Language: | Slovenian |
---|---|
Year of publishing: | 2013 |
Typology: | 1.04 - Professional Article |
Organization: | OI - Institute of Oncology |
UDC: | 616-006-085 |
COBISS: | 1681275 |
ISSN: | 1408-1741 |
Parent publication: | Onkologija |
Views: | 2458 |
Downloads: | 547 |
Average score: | 0 (0 votes) |
Metadata: |
Secondary language: | English |
---|---|
Secondary title: | Palliative sedation |
Secondary abstract: | Palliative sedation is the controlled use of medications intended to induce and maintain the state of reduced consciousness. In this state, the patient does not suffer from symptoms that we can no longer control (refractory symptoms). The most frequent reasons for palliative sedation are uncontrollable terminal anxiety and difficulty breathing. Midazolam is the medicine of choice for palliative sedation. The appropriate dose is determined by gradually increasing the initial dose until the desired effect – symptom control (titration) – is reached. The palliative sedation protocol sets out a clearly defined medical indication, the management and instructions for medical care as well as legal and ethical principles. Palliative sedation is not a synonym for euthanasia, nor does it shorten life. |
URN: | URN:NBN:SI |
Pages: | str. 109-110, 155 |
Volume: | ǂLetn. ǂ17 |
Issue: | ǂšt. ǂ2 |
Chronology: | dec. 2013 |
ID: | 10957631 |